文献速递母胎医学产科

染色体微阵列分析在先天性心脏病胎儿染色体异常及拷贝数变异产前诊断中的临床应用

Clinical application of chromosomal microarray analysis for the prenatal diagnosis of chromosomal abnormalities and copy number variations in fetuses with congenital heart disease.
PubMed 文献 · Prenat Diagn · 2018-04-27

本研究纳入产前超声心动图检出的110例先天性心脏病(CHD)胎儿,其中简单CHD 27例、复杂CHD 83例,采用Affymetrix CytoScan HD平台行染色体微阵列分析(CMA)。CMA检出6例染色体异常,致病性拷贝数变异(CNVs)检出率为15.5%(17/110),其中13例为CHD相关CNVs,并发现致病性CMA结果影响终止妊娠率。

要点

  • CMA在CHD胎儿中检出6例染色体异常,包括21三体2例、18三体2例、13三体1例及1例罕见的21三体嵌合体。
  • CHD胎儿中致病性CNVs检出率为15.5%(17/110),其中13例为CHD相关CNVs。
  • 致病性CMA结果影响终止妊娠率。

核心结论

  • CMA在识别CHD胎儿染色体异常和CNVs方面尤其有效,并影响产科结局。
  • 阐明CHD的遗传基础将继续拓展对CHD病因学的理解。

研究设计与样本

  • 研究纳入产前超声心动图检出的110例CHD胎儿,其中简单CHD 27例、复杂CHD 83例。
  • 采用Affymetrix CytoScan HD平台行CMA,所有注释的CNVs均经定量PCR验证。

主要发现

  • CMA检出6例染色体异常,包括21三体2例、18三体2例、13三体1例及1例罕见的21三体嵌合体。
  • 致病性CNVs检出率为15.5%(17/110),其中13例为CHD相关CNVs。
  • 通过基因功能富集分析,进一步鉴定出10个基因可能为新的CHD候选基因。
  • 致病性CMA结果影响终止妊娠率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to determine chromosomal abnormalities and copy number variations (CNVs) in fetuses with congenital heart disease (CHD) by chromosomal microarray analysis (CMA). METHODS: One hundred and ten cases with CHD detected by prenatal echocardiography were enrolled in the study; 27 cases were simple CHDs, and 83 were complex CHDs. Chromosomal microarray analysis was performed on the Affymetrix CytoScan HD platform. All annotated CNVs were validated by quantitative PCR. RESULTS: Chromosomal microarray analysis identified 6 cases with chromosomal abnormalities, including 2 cases with trisomy 21, 2 cases with trisomy 18, 1 case with trisomy 13, and 1 unusual case of mosaic trisomy 21. Pathogenic CNVs were detected in 15.5% (17/110) of the fetuses with CHDs, including 13 cases with CHD-associated CNVs. We further identified 10 genes as likely novel CHD candidate genes through gene functional enrichment analysis. We also found that pathogenic CMA results impacted the rate of pregnancy termination. CONCLUSIONS: This study shows that CMA is particularly effective for identifying chromosomal abnormalities and CNVs in fetuses with CHDs as well as having an effect on obstetrical outcomes. The elucidation of the genetic basis of CHDs will continue to expand our understanding of the etiology of CHDs.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Xia Y, Yang Y, Huang S, et al. Clinical application of chromosomal microarray analysis for the prenatal diagnosis of chromosomal abnormalities and copy number variations in fetuses with congenital heart disease. Prenat Diagn. 2018. PMID: 29573438. doi:10.1002/pd.5249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。